Table 1.
Factor | Count (%) N = 111 |
Estimated Hypothyroidism Incidence (%), Reported as Median (IQR) |
---|---|---|
Publication Year | ||
2000 and prior | 19 (17) | 34 (21–43) |
2001–2005 | 8 (7) | 44 (40–47) |
2006–2010 | 15 (14) | 31.6 (20.8–45.3) |
2011–2015 | 22 (20) | 33.3 (22.8–45) |
2016–2020 | 32 (29) | 42.3 (25–46.2) |
2021–2022 | 15 (14) | 42 (30.4–54.3) |
Design | ||
Prospective | 31 (28) | 37 (27.4–47) |
Retrospective | 80 (72) | 36.1 (24–46) |
Interventional | ||
Yes | 4 (4) | - |
No | 97 (96) | - |
Mean/Median Follow Up (months) | ||
Min | 6 | - |
First Quartile | 21 | - |
Median | 32 | - |
Third Quartile | 50.2 | - |
Max | 120 | - |
Unspecified/NA | 24 | - |
Sample size | Median 102 (62–184.75) | - |
Participant Type | ||
Patients | 99 (98) | - |
Physicians | 2 (2) | - |
Cancer Site | ||
General Head and Neck | 64 (58) | 36.7 (26–44.7) |
Nasopharynx | 28 (25) | 35 (23–46.2) |
Oropharynx | 6 (5) | 57.5 (35.3–62.5) |
Larynx/Hypopharynx | 10 (9) | 39.5 (28.7–48.7) |
Oral Cavity | 3 (3) | 17.9 (16.1–19.7) |
Radiation Therapy Modality | ||
Photons | 87 (78) | - |
Photons/Electrons | 2 (2) | - |
Particle Therapy | 0 | - |
Unspecified | 22 (20) | - |
Radiation Therapy Technique | ||
IMRT | 36 (32) | 42 (27.4–49.1) |
Non-IMRT (2D or 3DCRT) | 38 (34) | 35 (21.8–41.6) |
IMRT and 3DCRT | 10 (9) | 46.5 (27.5–50.8) |
MRI-guided radiotherapy | 0 | - |
Unspecified/NA | 27 (24) | 35 (23.9–48.2) |
Multimodality Therapy | ||
All therapies allowed | 89 (80) | 36.4 (24.8–45.7) |
Surgery excluded | 13 (12) | 38.8 (30–47) |
Surgery required | 4 (4) | 38.6 (26.2–50.5) |
Unspecified/NA | 5 (5) | 36.4 (25.4–48.2) |
Thyroid Evaluation | ||
Biochemical | 73 (66) | 38.8 (26.7–46.2) |
Clinical | 2 (2) | 4.9 |
Biochemical and Clinical | 32 (29) | 31.1 (23.9–49.5) |
Biochemical and Radiographic | 2 (2) | 42 |
Unspecified/NA * | 2 (2) | - |
Abbreviations: 2D and 3DCRT; two-dimensional and three-dimensional conformal radiation therapy, IMRT; intensity-modulated radiation therapy * Refers to studies investigating physician practices regarding screening for hypothyroidism and thus were considered Unspecified/NA.